The development of novel anticancer drugs is a critical area of pharmaceutical research, demanding constant innovation and access to specialized chemical compounds. 7-Methylquinazolin-4(3H)-one has emerged as a pivotal intermediate in the synthesis of many promising drug candidates within the quinazolinone class, known for their potent biological activities. NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in the supply chain, providing researchers and manufacturers with access to this vital compound.

The Foundation: 7-Methylquinazolin-4(3H)-one

With the CAS number 75844-40-5, 7-Methylquinazolin-4(3H)-one is a cornerstone for chemists engaged in the synthesis of complex heterocyclic molecules. Scientific literature outlines various synthetic methodologies, with a strong emphasis on achieving high purity and efficient yields. At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the quality of intermediates directly impacts the success of downstream applications. Therefore, we ensure our 7-Methylquinazolin-4(3H)-one consistently meets a purity standard of over 98%. As a leading supplier based in China, we offer competitive pricing and reliable bulk procurement options, facilitating seamless integration into research and manufacturing workflows.

Anticancer Applications and Research Findings

The significance of 7-Methylquinazolin-4(3H)-one is amplified by the potent anticancer activities observed in its derived compounds. Research has demonstrated that various synthetic modifications to this core structure can yield molecules with significant efficacy against cancer cell lines like HepG2 and MCF-7. These derivatives have shown cytotoxic effects that are often comparable to or even better than established chemotherapeutic agents, indicating a strong therapeutic potential. Pharmaceutical procurement managers seeking to buy these advanced compounds should look for suppliers with a proven track record in quality and consistency.

Computational Insights for Enhanced Drug Design

To accelerate the drug development process, computational tools such as molecular docking are increasingly utilized. These techniques allow researchers to visualize and analyze how potential drug molecules interact with specific biological targets, like enzymes critical for cancer cell survival. By predicting binding affinities and identifying key interactions, scientists can refine molecular designs for improved potency and selectivity. This data is invaluable when deciding which chemical intermediates to purchase for further investigation.

Ensuring Quality and Availability for Your Projects

NINGBO INNO PHARMCHEM CO.,LTD. is a trusted partner for the global scientific community, providing essential pharmaceutical intermediates like 7-Methylquinazolin-4(3H)-one. We are committed to supporting innovation in anticancer drug development through reliable supply, competitive pricing, and unwavering quality standards. We encourage you to contact us to discuss your procurement needs, request a quote for bulk purchases, and explore how our high-purity chemicals can advance your research objectives.